Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
Study of UK population-based heme malignancies and premalignancies cohort finds 5-year net relative disease-specific estimate of survival of MGUS pts was 87.8% (95% Cl 85.9-89.7), with males more affected than females.”
Title: Male sex adversely impacts survival and myeloid malignancy risk in MGUS: a real-world population-based study
Authors: Eve Roman, Timothy Bagguley, Simon Crouch, Alexandra Smith, Daniel Painter, Debra Howell, Russell Patmore, Reuben Tooze, Catherine Cargo, Ruth De Tute, Andrew Rawstron, Gordon Cook, Christopher Parrish, Frances Seymour.
You can read the Full Article in Haematologica.
You can find more posts featuring Robert Orlowski on OncoDaily.
